+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pain Management Devices Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2028

  • PDF Icon

    Report

  • 209 Pages
  • June 2021
  • Region: Global
  • Allied Market Research
  • ID: 5439666
Description Jump to:
The global pain management devices market was valued at $3,689.20 million in 2020, and is projected to reach $5,767.69 million by 2028, registering a CAGR of 6.3% from 2021 to 2028. Pain management devices are medical devices, which are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, and musculoskeletal pain. Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are different forms of pain management devices available in the market.



Significant increase in prevalence of chronic pain, rise in geriatric population, surge in awareness among people toward pain management devices, and increase in demand for pain management devices in developing regions are the key factors that fuel the growth of the market. Moreover, availability of innovative pain management devices, surge in R&D activities to develop technologically advanced pain management devices, increase in availability of lower cost portable products, and development of the medical device industry across the globe are other factors that contribute toward the growth of the market. However, hypersensitivity reactions and postoperative infections caused due to use of these devices limit their adoption. Moreover, they are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which hinders the growth of the market.

The pain management devices market is segmented into type, application, and region. By type, the market is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. Under the neuromodulation & neurostimulation devices segment, the market is further bifurcated into spinal cord stimulators and transcutaneous electrical nerve stimulation (TENS) devices. Under the analgesic infusion pumps, the pain management devices market is further divided into external infusion pumps and intrathecal infusion pumps. Depending on application, it is classified into cancer pain, neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key benefits for stakeholders

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2028, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global pain management devices market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS


By Type

  • Neuromodulation & Neurostimulation Devices o
  • Spinal Cord Stimulators
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • Analgesic Infusion Pumps
  • External Infusion Pumps
  • Intrathecal Infusion Pumps
  • Ablation Devices

By Application

  • Neuropathic Pain
  • Cancer Pain
  • Facial & Migraine Pain
  • Musculoskeletal Pain
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Abbott Laboratories
  • B Braun Melsungen AG
  • Baxter International Inc.
  • Boston Scientific Corp
  • Colfax Corporation (DJO Global LLC)
  • Johnson & Johnson (Codman and Shurtleff, Inc.)
  • Kimberly Clark Corporation
  • Medtronic Plc.
  • Pfizer, Inc.
  • Stryker Corp.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in prevalence of chronic diseases
3.5.1.2. Rise in geriatric population
3.5.1.3. Increase in adoption of pain management devices
3.5.2. Restraint
3.5.2.1. Preferable use of medications for pain management
3.5.3. Opportunity
3.5.3.1. Growth opportunities in emerging markets
3.5.4. Impact analysis
3.6. Covid-19 Impact analysis on pain management devices market
CHAPTER 4: PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Neuromodulation & neurostimulation devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.4.1. Spinal cord stimulators
4.2.4.1.1. Market size and forecast
4.2.4.2. Transcutaneous electrical nerve stimulation (TENS) devices
4.2.4.2.1. Market size and forecast
4.3. Analgesic infusion pumps
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. Market size and forecast, by type
4.3.4.1. External infusion pumps
4.3.4.1.1. Market size and forecast
4.3.4.2. Intrathecal infusion pumps
4.3.4.2.1. Market size and forecast
4.4. Ablation devices
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Neuropathic pain
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Cancer pain
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Facial & migraine pain
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Musculoskeletal pain
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Other
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
CHAPTER 6: PAIN MANAGEMENT DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. pain management devices market, by product
6.2.2.1.2. U.S. pain management devices market, by application
6.2.2.2. Canada
6.2.2.2.1. Canada pain management devices market, by product
6.2.2.2.2. Canada pain management devices market, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico pain management devices market, by product
6.2.2.3.2. Mexico pain management devices market, by application
6.2.3. North America market size and forecast, by product
6.2.4. North America market size and forecast, by application
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany pain management devices market, by product
6.3.2.1.2. Germany pain management devices market, by application
6.3.2.2. France
6.3.2.2.1. France pain management devices market, by product
6.3.2.2.2. France pain management devices market, by application
6.3.2.3. UK
6.3.2.3.1. UK pain management devices market, by product
6.3.2.3.2. UK pain management devices market, by application
6.3.2.4. Italy
6.3.2.4.1. Italy pain management devices market, by product
6.3.2.4.2. Italy pain management devices market, by application
6.3.2.5. Spain
6.3.2.5.1. Spain pain management devices market, by product
6.3.2.5.2. Spain pain management devices market, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe pain management devices market, by product
6.3.2.6.2. Rest of Europe pain management devices market, by application
6.3.3. Europe market size and forecast, by product
6.3.4. Europe market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan pain management devices market, by product
6.4.2.1.2. Japan pain management devices market, by application
6.4.2.2. China
6.4.2.2.1. China pain management devices market, by product
6.4.2.2.2. China pain management devices market, by application
6.4.2.3. Australia
6.4.2.3.1. Australia pain management devices market, by product
6.4.2.3.2. Australia pain management devices market, by application
6.4.2.4. India
6.4.2.4.1. India pain management devices market, by product
6.4.2.4.2. India pain management devices market, by application
6.4.2.5. South Korea
6.4.2.5.1. South Korea pain management devices market, by product
6.4.2.5.2. South Korea pain management devices market, by application
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific pain management devices market, by product
6.4.2.6.2. Rest of Asia-Pacific pain management devices market, by application
6.4.3. Asia-Pacific market size and forecast, by product
6.4.4. Asia-Pacific market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil pain management devices market, by product
6.5.2.1.2. Brazil pain management devices market, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia pain management devices market, by product
6.5.2.2.2. Saudi Arabia pain management devices market, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa pain management devices market, by product
6.5.2.3.2. South Africa pain management devices market, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA pain management devices market, by product
6.5.2.4.2. Rest of LAMEA pain management devices market, by application
6.5.3. LAMEA market size and forecast, by product
6.5.4. LAMEA market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. B BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. BAXTER INTERNATIONAL INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. BOSTON SCIENTIFIC CORPORATION
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. COLFAX CORPORATION (DJO GLOBAL LLC)
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. JOHNSON & JOHNSON (CODMAN AND SHURTLEFF, INC.)
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. KIMBERLY-CLARK CORPORATION (BAYLIS MEDICAL)
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. MEDTRONIC PLC
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. PFIZER INC. (HOSPIRA INC.)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. STRYKER CORPORATION
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
List of Tables
TABLE 01. PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 02. PAIN MANAGEMENT DEVICES MARKET FOR NEUROMODULATION & NEUROSTIMULATION DEVICES, BY REGION, 2020-2028 ($MILLION)
TABLE 03. PAIN MANAGEMENT DEVICES MARKET FOR NEUROMODULATION & NEUROSTIMULATION DEVICES, BY TYPE, 2020–2028 ($MILLION)
TABLE 04. PAIN MANAGEMENT DEVICES MARKET FOR ANALGESIC INFUSION PUMPS, BY REGION, 2020-2028 ($MILLION)
TABLE 05. PAIN MANAGEMENT DEVICES MARKET FOR ANALGESIC INFUSION PUMPS, BY TYPE, 2020–2028 ($MILLION)
TABLE 06. PAIN MANAGEMENT DEVICES MARKET FOR ABLATION DEVICES, BY REGION, 2020-2028 ($MILLION)
TABLE 07. PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 08. PAIN MANAGEMENT DEVICES MARKET FOR NEUROPATHIC PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 09. PAIN MANAGEMENT DEVICES MARKET FOR CANCER PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 10. PAIN MANAGEMENT DEVICES MARKET FOR FACIAL & MIGRAINE PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 11. PAIN MANAGEMENT DEVICES MARKET FOR MUSCULOSKELETAL PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 12. PAIN MANAGEMENT DEVICES MARKET FOR OTHER PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 13. PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 14. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 15. U.S. PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 16. U.S. PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 17. CANADA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 18. CANADA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 19. MEXICO PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 20. MEXICO PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 21. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 22. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 23. EUROPE PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 24. GERMANY PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 25. GERMANY PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 26. FRANCE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 27. FRANCE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 28. UK PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 29. UK PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 30. ITALY PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 31. ITALY PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 32. SPAIN PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 33. SPAIN PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 34. REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 35. REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 36. EUROPE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 37. EUROPE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 38. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 39. JAPAN PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 40. JAPAN PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 41. CHINA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 42. CHINA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 43. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 44. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 45. INDIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 46. INDIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 47. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 48. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 49. REST OF ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 50. REST OF ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 51. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 52. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 53. LAMEA PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 54. BRAZIL PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 55. BRAZIL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 56. SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 57. SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 58. SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 59. SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 60. REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 61. REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 62. LAMEA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 63. LAMEA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 64. ABBOTT: COMPANY SNAPSHOT
TABLE 65. ABBOTT: OPERATING SEGMENTS
TABLE 66. ABBOTT: PRODUCT PORTFOLIO
TABLE 67. B BRAUN: COMPANY SNAPSHOT
TABLE 68. B BRAUN: OPERATING SEGMENTS
TABLE 69. B BRAUN: PRODUCT PORTFOLIO
TABLE 70. BAXTER: COMPANY SNAPSHOT
TABLE 71. BAXTER: OPERATING SEGMENTS
TABLE 72. BAXTER: PRODUCT PORTFOLIO
TABLE 73. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 74. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 75. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 76. COLFAX: COMPANY SNAPSHOT
TABLE 77. COLFAX: OPERATING SEGMENTS
TABLE 78. COLFAX: PRODUCT PORTFOLIO
TABLE 79. J&J: COMPANY SNAPSHOT
TABLE 80. J&J: OPERATING SEGMENTS
TABLE 81. J&J: PRODUCT PORTFOLIO
TABLE 82. KIMBERLY-CLARK: COMPANY SNAPSHOT
TABLE 83. KIMBERLY-CLARK: OPERATING SEGMENTS
TABLE 84. KIMBERLY-CLARK: PRODUCT PORTFOLIO
TABLE 85. MEDTRONIC: COMPANY SNAPSHOT
TABLE 86. MEDTRONIC: OPERATING SEGMENTS
TABLE 87. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88. PFIZER INC.: COMPANY SNAPSHOT
TABLE 89. PFIZER: OPERATING SEGMENTS
TABLE 90. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 91. STRYKER: COMPANY SNAPSHOT
TABLE 92. STRYKER: OPERATING SEGMENTS
TABLE 93. STRYKER: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. PAIN MANAGEMENT DEVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. HIGH INTENSITY OF RIVALRY
FIGURE 11. MARKET PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR NEUROMODULATION & NEUROSTIMULATION DEVICES, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 14. SPINAL CORD STIMULATORS MARKET, 2020–2028 ($MILLION)
FIGURE 15. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES MARKET, 2020–2028 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR ANALGESIC INFUSION PUMPS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 17. EXTERNAL INFUSION PUMPS MARKET, 2020–2028 ($MILLION)
FIGURE 18. INTRATHECAL INFUSION PUMPS MARKET, 2020–2028 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR ABLATION DEVICES, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR CANCER PAIN, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR FACIAL & MIGRAINE PAIN, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR MUSCULOSKELETAL PAIN, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 24. COMPARATIVE ANALYSIS OF OTHERS PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 25. ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 26. ABBOTT: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 27. ABBOTT: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 28. B BRAUN: NET SALES, 2018–2020 ($MILLION)
FIGURE 29. B BRAUN: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 30. B BRAUN: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 31. BAXTER: NET SALES, 2018–2020 ($MILLION)
FIGURE 32. BAXTER: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 33. BAXTER: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 34. BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 35. BOSTON SCIENTIFIC: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 36. BOSTON SCIENTIFIC: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 37. COLFAX: NET SALES, 2018–2020 ($MILLION)
FIGURE 38. COLFAX: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 39. COLFAX: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 40. J&J: NET SALES, 2018–2020 ($MILLION)
FIGURE 41. J&J: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 42. J&J: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 43. KIMBERLY-CLARK: NET SALES, 2018–2020 ($MILLION)
FIGURE 44. KIMBERLY-CLARK: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 45. KIMBERLY-CLARK: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 46. MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 47. MEDTRONIC: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 48. MEDTRONIC: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 49. PFIZER INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 50. PFIZER INC.: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 51. PFIZER INC.: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 52. STRYKER: NET SALES, 2018–2020 ($MILLION)
FIGURE 53. STRYKER: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 54. STRYKER: REVENU.S.ARE BY REGION, 2020 (%)

Companies Mentioned

  • Abbott Laboratories
  • B Braun Melsungen AG
  • Baxter International Inc.
  • Boston Scientific Corp.
  • DJO Global LLC.
  • Johnson & Johnson (Codman And Shurtleff Inc.)
  • Kimberly Clark Corporation
  • Medtronic Plc.
  • Pfizer Inc.
  • Stryker Corp.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages209
PublishedJune 2021
Forecast Period2020 - 2028
Estimated Market Value ( USD ) in 2020 $ 3689.2 million
Forecasted Market Value ( USD ) by 2028 $ 5767.69 million
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pain Management Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 - Product Image

Pain Management Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  • Report
  • 150 Pages
  • Global
From
Global Market for Pain Management Drugs and Devices - Product Image

Global Market for Pain Management Drugs and Devices

  • Report
  • 171 Pages
  • Global
From
Global Pain Management Devices Market by Product (Analgesic Infusion Pumps, Electrical Stimulators, Neurostimulation), Application (Cancer, Facial & migraine, Musculoskeletal disorder), End-user - Forecast 2024-2030 - Product Image

Global Pain Management Devices Market by Product (Analgesic Infusion Pumps, Electrical Stimulators, Neurostimulation), Application (Cancer, Facial & migraine, Musculoskeletal disorder), End-user - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Global Pain Management Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Pain Management Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 113 Pages
  • Global
From
Pain Management Devices Market Size, Share & Trends Analysis Report By Application (Neuropathic, Cancer), By Product (RFA, Neurostimulation), By Region (North America, Asia Pacific), And Segment Forecasts, 2023-2030 - Product Image

Pain Management Devices Market Size, Share & Trends Analysis Report By Application (Neuropathic, Cancer), By Product (RFA, Neurostimulation), By Region (North America, Asia Pacific), And Segment Forecasts, 2023-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.